Lynley V. Marshall - Concepedia

Author

Lynley V. Marshall

Also Known As

L Marshall, L. Marshall, L. V. Marshall, L.V. Marshall, LV Marshall, Logan Marshall, Lynley Marshall, Lynley V Marshall, Lynley V. Marshall, Marshall, L

292

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Royal Marsden NHS Foundation Trust Institut Gustave Roussy Royal Marsden Hospital University College London

About

Lynley V. Marshall is an author at Institute of Cancer Research specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	1.1K
2	Health Sciences	5	5	242
3	Cell Biology	2	2	336
4	Public Health	1	1	22
5	Child Development	1	1	22

Lynley V. Marshall

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, The Lancet Oncology Interim AnalysisLymphoid NeoplasiaSurgical OncologyMedicineMelanoma	2019	324
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes Matthew Clarke, Alan Mackay, Britta Ismer, Cancer Discovery	2020	264
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells Maria Vinci, Anna Burford, Valeria Molinari, Nature Medicine Neuro-oncologyPediatric Brain TumorsSubclonal PopulationsGliomaTumor Heterogeneity	2018	178
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study Birgit Geoerger, C. Michel Zwaan, Lynley V. Marshall, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaHodgkin LymphomaMedicineNon-hodgkin Lymphoma	2019	162
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated <i>HOX</i>/Stem Cell Gene Signature Nathalie Gaspar, Lynley V. Marshall, Lara Perryman, Cancer Research High-grade GliomasCancer BiologyGliomaTumor BiologyResistance Gene Signature	2010	158
Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development Dorine A. Bax, Suzanne E. Little, Nathalie Gaspar, PLoS ONE	2009	124
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG) Ami V. Desai, Giles Robinson, Karen Gauvain, Neuro-Oncology	2022	121
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Nature Medicine	2023	112
EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines Dorine A. Bax, Nathalie Gaspar, Suzanne E. Little, Clinical Cancer Research	2009	97
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations Sally L. George, Elisa Izquierdo, James Campbell, European Journal of Cancer	2019	90

Page 1